Litigation Details for POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (D.N.J. 2015)
✉ Email this page to a colleague
POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (D.N.J. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-10-22 |
| Court | District Court, D. New Jersey | Date Terminated | 2019-09-10 |
| Cause | 15:78m(a) Securities Exchange Act | Assigned To | Michael Andre Shipp |
| Jury Demand | Both | Referred To | Rukhsanah L. Singh |
| Parties | BLACKROCK GLOBAL MULTI ASSET INCOME FUND HIGH YIELD PORTFOLIO; LORD ABBETT SHORT DURATION CREDIT TRUST | ||
| Patents | 6,861,053; 7,045,620; 7,326,711; 7,452,857; 7,605,240; 7,612,199; 7,902,206; 7,906,542; 7,915,275; 8,158,644; 8,158,781; 8,193,196; 8,309,569; 8,518,949; 8,642,573; 8,741,904; 8,829,017; 8,835,452; 8,853,231; 8,946,252; 8,969,398 | ||
| Attorneys | JENNIFER FIORICA DELGADO; KAREN M. LERNER | ||
| Firms | Kirby McInerney LLP; Skoloff & Wolfe, Pc | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2016-09-13 | 167 | Exhibit 31-48 | Patent No. 6,861,053 (the “‘053 patent”), U.S. Patent No. 7,452,857 (the “‘857 patent”), U.S. Patent No. 7,…620 patent, the ‘199 patent, the ‘206 patent, the ‘542 patent, the ‘275 patent, the ‘644 patent, the…of the ‘569 patent, the ‘573 patent, the ‘017 patent, the ‘252 patent and the ‘398 patent. Alfa Wassermann…the ‘781 patent, the ‘196 patent, the ‘949 patent, the ‘904 patent, the ‘452 patent and the ‘231 patent…of the ‘053 patent, the ‘857 patent, the ‘240 patent, the ‘608 patent and the ‘799 patent , each of which | External link to document |
| 2020-04-22 | 539 | Exhibit Seeger Decl Ex. H - Class Cert Brief | .86 $93.88 $93.91 7,326,711 1.74% 12/9/2015 $94.40 …Allergan PLC was challenging the patent to a key drug, and then saw Moody's put it | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
